This protective association has been repeatedly observed, linking GLP-1RA use to lower risks of POAG, ocular hypertension, and the need for first-line glaucoma treatment in large cohorts of T2DM patients [105,106,107]
Sanders also recommends two go-tos: "Microneedling and/or radiofrequency treatments will also tighten lax skin, and the use of fillers to provide necessary soft tissue support is also helpful." On the derm front, Dallas dermatologist Elizabeth Houshmand, MD is seeing it, too, and calls out this interesting study, published by Dermatology Times , which holds promising results for these specific patients: "A novel skin-care treatment has been developed for patients with reduced facial skin quality due to the use of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors
Meanwhile, GLP-1 contributes to better regulation of blood sugar levels
Finally, GLP-1s slow down digestion, changing the way a person's body turns food into energy